ArticleOncotarget2017

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.

Shinya Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.